1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Urinary Tract Infections
1.2.3 Surgical Site Infections
1.2.4 Hospital-acquired Pneumonia
1.2.5 BloodStream Infections
1.2.6 Gastrointestinal Infections
1.3 Market by Application
1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2017-2028)
2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Healthcare-associated Infectious Disease Diagnostics Market Dynamics
2.3.1 Healthcare-associated Infectious Disease Diagnostics Industry Trends
2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2021
3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2023-2028)
5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
6.2.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
6.4.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type
7.2.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application
7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
7.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
9.2.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
9.3.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
9.4.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.2.5 Accelerate Diagnostics Recent Developments
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.3.5 BD Recent Developments
11.4 bioMrieux
11.4.1 bioMrieux Company Details
11.4.2 bioMrieux Business Overview
11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.4.5 bioMrieux Recent Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.5.5 Bio-Rad Recent Developments
11.6 DiaSorin Molecular
11.6.1 DiaSorin Molecular Company Details
11.6.2 DiaSorin Molecular Business Overview
11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.6.5 DiaSorin Molecular Recent Developments
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.7.5 F. Hoffmann-La Roche Recent Developments
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.8.5 Luminex Recent Developments
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.9.5 Meridian Bioscience Recent Developments
11.10 OpGen
11.10.1 OpGen Company Details
11.10.2 OpGen Business Overview
11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.10.5 OpGen Recent Developments
11.11 QIAGEN
11.11.1 QIAGEN Company Details
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.11.5 QIAGEN Recent Developments
11.12 Quidel
11.12.1 Quidel Company Details
11.12.2 Quidel Business Overview
11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.12.5 Quidel Recent Developments
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.13.5 Thermo Fisher Scientific Recent Developments
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Details
11.14.2 Trinity Biotech Business Overview
11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.14.5 Trinity Biotech Recent Developments
11.15 Danaher
11.15.1 Danaher Company Details
11.15.2 Danaher Business Overview
11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
11.15.5 Danaher Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Urinary Tract Infections
Table 3. Key Players of Surgical Site Infections
Table 4. Key Players of Hospital-acquired Pneumonia
Table 5. Key Players of BloodStream Infections
Table 6. Key Players of Gastrointestinal Infections
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2017-2022)
Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2023-2028)
Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends
Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Players (2017-2022)
Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2021)
Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2017-2022)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2023-2028)
Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Application (2017-2022)
Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Application (2023-2028)
Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Healthcare-associated Infectious Disease Diagnostics Product
Table 67. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 68. Abbott Recent Developments
Table 69. Accelerate Diagnostics Company Details
Table 70. Accelerate Diagnostics Business Overview
Table 71. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
Table 72. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 73. Accelerate Diagnostics Recent Developments
Table 74. BD Company Details
Table 75. BD Business Overview
Table 76. BD Healthcare-associated Infectious Disease Diagnostics Product
Table 77. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 78. BD Recent Developments
Table 79. bioMrieux Company Details
Table 80. bioMrieux Business Overview
Table 81. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
Table 82. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 83. bioMrieux Recent Developments
Table 84. Bio-Rad Company Details
Table 85. Bio-Rad Business Overview
Table 86. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
Table 87. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 88. Bio-Rad Recent Developments
Table 89. DiaSorin Molecular Company Details
Table 90. DiaSorin Molecular Business Overview
Table 91. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
Table 92. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 93. DiaSorin Molecular Recent Developments
Table 94. F. Hoffmann-La Roche Company Details
Table 95. F. Hoffmann-La Roche Business Overview
Table 96. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
Table 97. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 98. F. Hoffmann-La Roche Recent Developments
Table 99. Luminex Company Details
Table 100. Luminex Business Overview
Table 101. Luminex Healthcare-associated Infectious Disease Diagnostics Product
Table 102. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 103. Luminex Recent Developments
Table 104. Meridian Bioscience Company Details
Table 105. Meridian Bioscience Business Overview
Table 106. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
Table 107. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 108. Meridian Bioscience Recent Developments
Table 109. OpGen Company Details
Table 110. OpGen Business Overview
Table 111. OpGen Healthcare-associated Infectious Disease Diagnostics Product
Table 112. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 113. OpGen Recent Developments
Table 114. QIAGEN Company Details
Table 115. QIAGEN Business Overview
Table 116. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
Table 117. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 118. QIAGEN Recent Developments
Table 119. Quidel Company Details
Table 120. Quidel Business Overview
Table 121. Quidel Healthcare-associated Infectious Disease Diagnostics Product
Table 122. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 123. Quidel Recent Developments
Table 124. Thermo Fisher Scientific Company Details
Table 125. Thermo Fisher Scientific Business Overview
Table 126. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
Table 127. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 128. Thermo Fisher Scientific Recent Developments
Table 129. Trinity Biotech Company Details
Table 130. Trinity Biotech Business Overview
Table 131. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
Table 132. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 133. Trinity Biotech Recent Developments
Table 134. Danaher Company Details
Table 135. Danaher Business Overview
Table 136. Danaher Healthcare-associated Infectious Disease Diagnostics Product
Table 137. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
Table 138. Danaher Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Urinary Tract Infections Features
Figure 3. Surgical Site Infections Features
Figure 4. Hospital-acquired Pneumonia Features
Figure 5. BloodStream Infections Features
Figure 6. Gastrointestinal Infections Features
Figure 7. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. ASCs Case Studies
Figure 11. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region: 2021 VS 2028
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2021
Figure 16. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2021
Figure 18. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 20. North America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 22. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 26. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 27. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 28. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Share by Region (2017-2028)
Figure 38. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 48. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
Figure 54. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 58. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 59. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 60. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 61. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 62. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 64. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 65. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 66. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 67. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 68. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 69. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 70. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 71. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
